Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

(2017) Radha Rajasingham et al.   LANCET INFECTIOUS DISEASES

CD4 + T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis

(2017) Lori M. Neal et al.   mBio

Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy

(2016) Peter R. Williamson et al.   Nature Reviews Neurology

Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence

(2016) Jairo M. Montezuma-Rusca et al.   PLoS One

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis

(2015) Anil A. Panackal et al.   PLoS Pathogens

Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis

(2015) Joseph N. Jarvis et al.   PLoS Pathogens

Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome

(2014) D. B. Meya et al.   JOURNAL OF INFECTIOUS DISEASES

Cryptococcosis in Solid Organ Transplantation

(2013) J. W. Baddley et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis

(2013) Joseph N. Jarvis et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemiology of Cryptococcal Meningitis in the US: 1997–2009

(2013) Vasilios Pyrgos et al.   PLoS One

Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination

(2013) D. Furman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis

(2011) A. Loyse et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis

(2010) J. M. Lestner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

(2010) Lewis J Haddow et al.   LANCET INFECTIOUS DISEASES

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study

(2009) Somnuek Sungkanuparph et al.   CLINICAL INFECTIOUS DISEASES

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis

(2008) Françoise Dromer et al.   PLoS One